Business
Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets...
Hi, what are you looking for?
Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets...
The Technion team has won a gold medal in the international iGEM competition for the second year in a row. In addition to...
Shanghai Jiao Tong University's latest rankings find the Hebrew University climbing three places to 67. Technion ranked 77.
These are some of the hottest startups in Israel that are creating some of the fastest growing companies on the planet.
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Erez Vigodman: Size isn't everything; it's important to be better.
In the 21st Jun 2015 edition of Israel’s good news, the highlights include: · Three important stomach-related medical developments from Israeli scientists. ·...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Teva says it will seek ‘further appellate review’